Pricing Log in Create free account

Immunovant, Inc. (IMVT) vs Kodiak Sciences Inc. (KOD)

Immunovant, Inc. and Kodiak Sciences Inc. are both Biotechnology companies. Immunovant, Inc. and Kodiak Sciences Inc. are of similar size ($5.7B and $5.5B). Across the 8 metrics below, Immunovant, Inc. leads on 5 and Kodiak Sciences Inc. on 3.

Valuation

Metric IMVT KOD Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 7.47 87.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.55%) (4.89%) (33.15%)
Free cash flow yield (7.55%) (2.98%) (25.50%)

Profitability

Metric IMVT KOD Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.10%) (368.37%) (56.36%)
Return on assets (71.10%) (94.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMVT KOD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (1.47%) (28.96%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMVT KOD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.27 2.49 4.72
Net debt to EBITDA 1.69 1.01 0.96

Dividend

Metric IMVT KOD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMVT KOD Biotechnology median
Market cap 5.68b 5.54b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack